Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Product availability issue? 96 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Product availability issue have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.2% of all adverse event reports for CLONAZEPAM.

96
Reports of Product availability issue with CLONAZEPAM
0.2%
of all CLONAZEPAM reports
1
Deaths
19
Hospitalizations

How Dangerous Is Product availability issue From CLONAZEPAM?

Of the 96 reports, 1 (1.0%) resulted in death, 19 (19.8%) required hospitalization, and 8 (8.3%) were considered life-threatening.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 96 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which CLONAZEPAM Alternatives Have Lower Product availability issue Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Product availability issue Reports All Drugs Causing Product availability issue CLONAZEPAM Demographics